study of some biomarkers of breast cancer

Novel cancer biomarker signatures for early and improved detection and diagnostics, that in the long run also could be used to predict tumour relapses, monitor treatment, is essential, The aim of this review is to provide an overview of the pathophysiology, clinical and analytical characteristics of biomarkers that may have potential clinical utility to identify and risk assessment of breast caner patients.